Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BSP:PNVL3'
s Days Inventory Range Over the Past 10 Years
Min: 75.44 Med: 99.51 Max: 116.44
Current: 102.47
During the past 13 years, Dimed Distribuidora de Medicamentos's highest Days Inventory was 116.44. The lowest was 75.44. And the median was 99.51.
BSP:PNVL3's Days Inventory is ranked better than 78.22% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs BSP:PNVL3: 102.47
Inventory Turnover measures how fast the company turns over its inventory within a year.
Dimed Distribuidora de Medicamentos's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.91.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dimed Distribuidora de Medicamentos's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.81.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Dimed Distribuidora de Medicamentos's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Dimed Distribuidora de Medicamentos's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Dimed Distribuidora de Medicamentos Days Inventory Related Terms
Dimed Distribuidora de Medicamentos Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos Days Inventory Chart
BSP:PNVL3 vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dimed Distribuidora de Medicamentos Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Days Inventory distribution charts can be found below:
* The bar in red indicates where Dimed Distribuidora de Medicamentos's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Days Inventory of 100.31 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dimed Distribuidora de Medicamentos and its competitors. This is near median its historical median of 99.51. Over the past decade, Dimed Distribuidora de Medicamentos' Days Inventory has ranged from 75.44 to 116.44. According to the industry distribution chart, Dimed Distribuidora de Medicamentos ranks #201 out of 923 companies in the Drug Manufacturers industry, placing it in the top 21.8%.
Is Dimed Distribuidora de Medicamentos' Days Inventory too high?
Dimed Distribuidora de Medicamentos' current Days Inventory of 100.31 is near median its 10-year median of 99.51. Over the past 10 years, this metric has ranged from a low of 75.44 to a high of 116.44. The Drug Manufacturers industry median Days Inventory is 164.48. Dimed Distribuidora de Medicamentos' value of 100.31 is 39% below this industry median. Based on the distribution chart, Dimed Distribuidora de Medicamentos ranks #201 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dimed Distribuidora de Medicamentos ranks #201 out of 923 companies for Days Inventory. This places Dimed Distribuidora de Medicamentos in the top 22% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Dimed Distribuidora de Medicamentos' value of 100.31 is 39% below this benchmark. Historically, Dimed Distribuidora de Medicamentos' own Days Inventory has ranged from 75.44 to 116.44 over the past decade. While the company's 10-year median is 99.51 vs. the industry median of 164.48, Dimed Distribuidora de Medicamentos has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dimed Distribuidora de Medicamentos's current Days Inventory of 100.31 is 39% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Dimed Distribuidora de Medicamentos and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dimed Distribuidora de Medicamentos's current Days Inventory is 100.31, which is near median its own 10-year median of 99.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.64, compared to a current price of R$11.17 — trading 18.1% below its estimated fair value. The current Days Inventory is 100.31, which is near median its 10-year median of 99.51 and 39% below the Drug Manufacturers industry median of 164.48. Dimed Distribuidora de Medicamentos' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Days Inventory is 100.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued.
The current stock price of R$11.17 is trading 18.1% below its estimated GF Value™ of R$13.64.
GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.
Key valuation signals for BSP:PNVL3:
Days Inventory: 100.31 (near median its 10-year median of 99.51)
GF Value™: R$13.64 vs. price of R$11.17 (18.1% below fair value)
Industry Position: 39% below the Drug Manufacturers median (#201 of 923)
No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dimed Distribuidora de Medicamentos Business Description
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
89GF Score
Get the complete analysis for BSP:PNVL3
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PNVL3 has been successfully added to your 
